169 related articles for article (PubMed ID: 27792999)
1. Genetic variant in visfatin gene promoter contributes to reduced risk of hepatocellular carcinoma in a Chinese population.
Wu Z; Sun Y; Huang Y; Zhu S; Feng Y; Ye H; Liu C; Tang S
Oncotarget; 2016 Nov; 7(47):77968-77977. PubMed ID: 27792999
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population.
Li S; Deng Y; Chen ZP; Huang S; Liao XC; Lin LW; Li H; Peng T; Qin X; Zhao JM
Infect Genet Evol; 2011 Dec; 11(8):2083-8. PubMed ID: 22019522
[TBL] [Abstract][Full Text] [Related]
3. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
[TBL] [Abstract][Full Text] [Related]
4. Association between catalase gene polymorphisms and risk of chronic hepatitis B, hepatitis B virus-related liver cirrhosis and hepatocellular carcinoma in Guangxi population: a case-control study.
Liu Y; Xie L; Zhao J; Huang X; Song L; Luo J; Ma L; Li S; Qin X
Medicine (Baltimore); 2015 Apr; 94(13):e702. PubMed ID: 25837767
[TBL] [Abstract][Full Text] [Related]
5. Association of Hypoxia-Inducible Factor-2 Alpha Gene Polymorphisms with the Risk of Hepatitis B Virus-Related Liver Disease in Guangxi Chinese: A Case-Control Study.
Huang L; Liu C; Deng Y; Liu Y; Zhao J; Huang X; Tang W; Sun Y; Qin X; Li S
PLoS One; 2016; 11(7):e0158241. PubMed ID: 27384772
[TBL] [Abstract][Full Text] [Related]
6. Association between the rs9131 and rs3806792 polymorphisms of the CXCL2 gene and the risk of HBV-related hepatocellular carcinoma in a Guangxi population.
Lu Y; Zeng J; Yang S; Hu Z; Li L; Yu H; Qin X
J Clin Lab Anal; 2020 Aug; 34(8):e23310. PubMed ID: 32267022
[TBL] [Abstract][Full Text] [Related]
7. Genetic variants in IL12 influence both hepatitis B virus clearance and HBV-related hepatocellular carcinoma development in a Chinese male population.
Tan A; Gao Y; Yao Z; Su S; Jiang Y; Xie Y; Xian X; Mo Z
Tumour Biol; 2016 May; 37(5):6343-8. PubMed ID: 26631030
[TBL] [Abstract][Full Text] [Related]
8. Association between polymorphisms of the
He XT; Xu HQ; Wang XM; He XS; Niu JQ; Gao PJ
World J Gastroenterol; 2017 Jan; 23(2):232-241. PubMed ID: 28127197
[TBL] [Abstract][Full Text] [Related]
9. TIM3 gene polymorphisms in patients with chronic hepatitis B virus infection: impact on disease susceptibility and hepatocellular carcinoma traits.
Li Z; Liu Z; Zhang G; Han Q; Li N; Zhu Q; Lv Y; Chen J; Xing F; Wang Y; Li F
Tissue Antigens; 2012 Aug; 80(2):151-7. PubMed ID: 22587604
[TBL] [Abstract][Full Text] [Related]
10. C-reactive protein genetic polymorphisms increase susceptibility to HBV-related hepatocellular carcinoma in a Chinese population.
Peng Q; Ren S; Lao X; Lu Y; Zhang X; Chen Z; Qin X; Li S
Tumour Biol; 2014 Oct; 35(10):10169-76. PubMed ID: 25027406
[TBL] [Abstract][Full Text] [Related]
11. The Effect of ICOS Polymorphism Interactions with HBV Mutations on HBV Subtype Infection Outcomes.
Song XM; Li QL; Guo F; Peng H; Guo JJ
Ann Hepatol; 2018 Oct; 17(6):940-947. PubMed ID: 30600290
[TBL] [Abstract][Full Text] [Related]
12. PNPLA3 rs738409 is not associated with the risk of hepatocellular carcinoma and persistent infection of hepatitis B virus (HBV) in HBV-related subjects: A case-control study and meta-analysis on Asians.
Wang P; Wu C; Li Y; Gong Y; Shen N
Gene; 2020 Jun; 742():144585. PubMed ID: 32173542
[TBL] [Abstract][Full Text] [Related]
13. Association of the GLB1 rs4678680 genetic variant with risk of HBV-related hepatocellular carcinoma.
Wang WT; Li Z; Shi M; Zhu H; Xiong X; Shang J; Liu J; Teng M; Yang M
Oncotarget; 2016 Aug; 7(35):56501-56507. PubMed ID: 27489354
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-21 gene polymorphisms and chronic hepatitis B infection in a Chinese population.
Yao JY; Chao K; Li MR; Wu YQ; Zhong BH
World J Gastroenterol; 2015 Apr; 21(14):4232-9. PubMed ID: 25892873
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms of C-reactive protein increase susceptibility to HBV-related hepatocellular carcinoma in a Guangxi male population.
Lao X; Ren S; Lu Y; Yang D; Qin X; Li S
Int J Clin Exp Pathol; 2015; 8(12):16055-63. PubMed ID: 26884882
[TBL] [Abstract][Full Text] [Related]
16. Association of IL-2 polymorphisms and IL-2 serum levels with susceptibility to HBV-related hepatocellular carcinoma in a Chinese Zhuang population.
Peng Q; Li H; Lao X; Deng Y; Chen Z; Qin X; Li S
Infect Genet Evol; 2014 Oct; 27():375-81. PubMed ID: 25173083
[TBL] [Abstract][Full Text] [Related]
17. Relationships between the Osteocalcin gene polymorphisms, serum osteocalcin levels, and hepatitis B virus-related hepatocellular carcinoma in a Chinese population.
Liu Y; Huang L; Lu Y; Xi XE; Huang XL; Lu Q; Huang X; Li S; Qin X
PLoS One; 2015; 10(1):e0116479. PubMed ID: 25587715
[TBL] [Abstract][Full Text] [Related]
18. The role of IL22 polymorphisms on liver cirrhosis in patients with hepatitis B virus: A case control study.
Gao YH; Li QQ; Wang CG; Sun J; Wang XM; Li YJ; He XT; Xu HQ; Niu JQ
Medicine (Baltimore); 2019 Nov; 98(44):e17867. PubMed ID: 31689880
[TBL] [Abstract][Full Text] [Related]
19. Association of TAP1 and TAP2 polymorphisms with the outcome of persistent HBV infection in a northeast Han Chinese population.
Qiu B; Huang B; Wang X; Liang J; Feng J; Chang Y; Li D
Scand J Gastroenterol; 2012 Nov; 47(11):1368-74. PubMed ID: 22989262
[TBL] [Abstract][Full Text] [Related]
20. Association of single nucleotide polymorphisms in VDR and DBP genes with HBV-related hepatocellular carcinoma risk in a Chinese population.
Peng Q; Yang S; Lao X; Li R; Chen Z; Wang J; Qin X; Li S
PLoS One; 2014; 9(12):e116026. PubMed ID: 25541958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
